首页 > 市场调查报告书 > 製药

药物开发临床实验临床开发

市场调查报告书

商品编码

1402453

2028 年欧洲临床试验市场预测 - 区域分析 - 按研究设计、阶段和适应症

Europe Clinical Trials Market Forecast to 2028 - Regional Analysis - by Study Design, Phase, and Indication

出版日期: 2023年10月26日 | 出版商:

The Insight Partners | 英文 148 Pages | 订单完成后即时交付

价格

简介目录图表

欧洲临床试验市场预计将从2022年的157.3935亿美元成长到2028年的216.4387亿美元。预计2022年至2028年CAGR为5.5%。

临床试验的采用和外包的增加推动了欧洲临床试验市场。

临床试验有助于确定新的治疗或预防形式（例如新药、饮食或医疗设备）是否安全有效。试验主要在药物开发过程中进行。根据欧洲药品管理局统计，欧盟（EU）每年授权约4,000项临床试验，其中约60%的临床试验与製药业相关。由于慢性病盛行率的上升，越来越多的用于开发不同有效治疗方法的临床试验正在推动临床试验市场的成长。

此外，临床试验的程序越来越复杂，因此对研究组织中发生的操作的正确执行和监督变得至关重要。为了避免因执行不当而出现错误，研究型组织正在外包临床试验来开发其产品。临床研究组织 (CRO) 透过使用高品质设施和深厚的主题专业知识提供的服务，协助成功实施临床试验。 CRO 已开始透过其高效且具成本效益的营运使试验申办者受益，成为临床试验产业的支柱。因此，开发具有成本效益的解决方案以及减少药物开发过程中 CRO 的错误正在推动临床试验市场的成长。

欧洲临床试验市场概况

欧洲临床试验市场已细分为英国、德国、法国、义大利、西班牙和欧洲其他地区。公司新药开发和创新产品推出的临床试验活动数量不断增加，可能会在预测期内促进欧洲市场的成长。

癌症、心血管疾病、神经系统疾病和传染病是德国临床试验中最常研究的疾病。临床研究受惠于德国完善的交通、通讯、能源和公共服务基础设施，而且该国患者群体庞大，对优质医疗保健的需求很高。临床试验协调中心是联邦教育和研究部新资助计画的一部分，旨在促进学术临床研究。德国的临床试验由联邦药品和医疗器材研究所或保罗-埃利希研究所批准，具体取决于要研究的产品。因此，德国的临床试验审批流程标准化、可靠、透明，且核准的研究启动时间相对较短。此外，德国顶级 CRO 提供多种临床试验服务。 Sofpromed 管理德国和其他欧盟成员国的临床试验。它为製药和生物技术公司提供全方位的CRO服务。同样，总部位于德国曼海姆的 CONET GmbH 提供从小型试点研究到所有阶段 (1-4) 的大型多中心国际临床试验的临床试验管理服务，包括根据欧盟指令的儿科临床试验和医疗器械试验。

欧洲临床试验市场收入及2028年预测（百万美元）

欧洲临床试验市场细分

欧洲临床试验市场分为阶段、研究设计、适应症和国家。

根据阶段，欧洲临床试验市场分为 I 期、II 期、III 期和 IV 期。 2022 年，III 期临床试验市占率将成为欧洲最大的临床试验市场。

根据研究设计，欧洲临床试验市场分为介入性、观察性和扩展性。 2022 年，介入性细分市场将占据欧洲最大的临床试验市场。

根据适应症，欧洲临床试验市场分为自体免疫/发炎、疼痛管理、肿瘤、中枢神经系统疾病、糖尿病、肥胖、心血管等。到 2022 年，肿瘤学领域将占据欧洲最大的临床试验市场。

根据国家/地区，欧洲临床试验市场分为英国、德国、法国、义大利、西班牙和欧洲其他地区。 2022年，德国在欧洲临床试验市场占据主导地位。

Charles River Laboratories International Inc、ICON Plc、IQVIA Holdings Inc、IXICO Plc、Laboratory Corp of America Holdings、Parexel International Corp、SGS SA、Syneos Health Inc、Thermo Fisher Scientific Inc 和 WuXi AppTec Co Ltd. 都是领先公司在欧洲临床试验市场运作。

Clinical trials help determine if a new form of treatment or prevention, such as a new drug, diet, or medical device, is safe and effective. The trials are mainly carried out during drug development. According to European Medicine Agency, in the European Union (EU), ~4,000 clinical trials are authorized annually, of which about 60% of clinical trials are associated with the pharmaceutical industry. An increasing number of clinical trials for developing different effective treatments due to the rising prevalence of chronic diseases is fueling the growth of the clinical trials market.

Further, clinical trials are increasingly becoming complex procedures, owing to which proper execution and overseeing of the operation occurring in research-based organizations has become crucial. To avoid errors due to improper execution, research-based organizations are outsourcing clinical trials to develop their products. Clinical research organizations (CROs) assist in successfully implementing clinical trials through the services offered using high-quality facilities and deep subject matter expertise. CROs have begun acting as a backbone of the clinical trial industry through their efficient and cost-effective operations benefitting trial sponsors. Thus, the development of cost-effective solutions and decreasing errors in CROs during the drug development process are driving the clinical trials market growth.

Europe Clinical Trials Market Overview

The Europe clinical trials market has been segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. The rising number of clinical trial activities for new drug development and innovative product launches by the companies will likely enhance the market growth in Europe during the forecast period.

Cancer, cardiovascular illness, nervous system disorders, and infectious diseases are the most frequently studied conditions in clinical trials in Germany. Clinical research benefits from Germany's well-established transport, communication, energy, and public services infrastructure, Moreover, there is a large patient pool and a high demand for quality healthcare in the country. Coordinating centers for clinical trials were established as part of a new funding program under the Federal Ministry of Education and Research to foster academic clinical research. Clinical trials in Germany are approved by the Federal Institute for Drugs and Medical Devices or the Paul-Ehrlich Institute, depending on the product to be investigated. Therefore, Germany's clinical trial approval processes are standardized, reliable, transparent, and approved for relatively short study start-up timelines. Further, top CROs in Germany provide several clinical trial services. Sofpromed manages clinical trials in Germany and other EU member states. It offers a full range of CRO services for pharmaceutical and biotechnology companies. Similarly, CONET GmbH, headquartered in Mannheim, Germany, offers clinical trial management services from small pilot studies to large multicenter international clinical trials for all phases (1-4), including pediatric clinical trials and medical device trials as per EU Directives.

Europe clinical trials market Revenue and Forecast to 2028 (US$ Million)

Europe Clinical Trials Market Segmentation

The Europe clinical trials market is segmented into phase, study design, indication, and country.

Based on phase, the Europe clinical trials market is segmented into phase I, phase II, phase III, and phase IV. The phase III segment registered the largest Europe clinical trials market share in 2022.

Based on study design, the Europe clinical trials market is segmented into interventional, observational, and expanded access. The interventional segment held the largest Europe clinical trials market share in 2022.

Based on indication, the Europe clinical trials market is segmented into autoimmune/inflammation, pain management, oncology, CNS condition, diabetes, obesity, cardiovascular, and others. The oncology segment held the largest Europe clinical trials market share in 2022.

Based on country, the Europe clinical trials market has been categorized into the UK, Germany, France, Italy, Spain, and Rest of Europe. Germany dominated the Europe clinical trials market in 2022.

Charles River Laboratories International Inc, ICON Plc, IQVIA Holdings Inc, IXICO Plc, Laboratory Corp of America Holdings, Parexel International Corp, SGS SA, Syneos Health Inc, Thermo Fisher Scientific Inc, and WuXi AppTec Co Ltd. are some of the leading companies operating in the Europe clinical trials market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe clinical trials market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe clinical trials market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the clinical trials market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Europe Clinical Trials Market - By Phase
- 1.3.2 Europe Clinical Trials Market - By Study Design
- 1.3.3 Europe Clinical Trials Market - By Indication
- 1.3.4 Europe Clinical Trials Market - By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Clinical Trials Market - Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 Europe PEST Analysis
4.3 Experts Opinion

5. Europe Clinical Trials Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Adoption and Outsourcing of Clinical Trials
- 5.1.2 Flourishing Pharmaceutical Industry and Increasing R&D Activities in Pharmaceutical Industry
5.2 Market Restraints
- 5.2.1 Expensive and Time-Consuming Process
5.3 Market Opportunities
- 5.3.1 Adoption of Decentralized Clinical Trials and Hybrid Clinical Trials
5.4 Future Trends
- 5.4.1 AI-Driven Clinical Trials
5.5 Impact Analysis

6. Clinical Trials Market - Europe Analysis

6.1 Europe Clinical Trials Market Revenue Forecast and Analysis

7. Europe Clinical Trials Market Revenue and Forecast To 2028 - by Study Design

7.1 Overview
7.2 Europe Clinical Trials Market Revenue Share, by Study Design (2022 and 2028)
7.3 Interventional
- 7.3.1 Overview
- 7.3.2 Interventional: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Observational
- 7.4.1 Overview
- 7.4.2 Observational: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Expanded Access
- 7.5.1 Overview
- 7.5.2 Expanded Access: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)

8. Europe Clinical Trials Market - By Phase

8.1 Overview
8.2 Europe Clinical Trials Market, by Phase, 2022 and 2028 (%)
8.3 Phase III
- 8.3.1 Overview
- 8.3.2 Phase III: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Phase II
- 8.4.1 Overview
- 8.4.2 Phase II: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Phase IV
- 8.5.1 Overview
- 8.5.2 Phase IV: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Phase I
- 8.6.1 Overview
- 8.6.2 Phase I: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)

9. Europe Clinical Trials Market Revenue and Forecast To 2028 - Indication

9.1 Overview
9.2 Europe Clinical Trials Market Revenue Share, by Indication (2022 and 2028)
9.3 Autoimmune/Inflammation
- 9.3.1 Overview
- 9.3.2 Autoimmune/Inflammation: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Pain Management
- 9.4.1 Overview
- 9.4.2 Pain Management: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Oncology
- 9.5.1 Overview
- 9.5.2 Oncology: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.6 CNS Condition
- 9.6.1 Overview
- 9.6.2 CNS Condition: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.7 Diabetes
- 9.7.1 Overview
- 9.7.2 Diabetes: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.8 Obesity
- 9.8.1 Overview
- 9.8.2 Obesity: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.9 Cardiovascular
- 9.9.1 Overview
- 9.9.2 Cardiovascular: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.10 Other
- 9.10.1 Overview
- 9.10.2 Other: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)

10. Europe Clinical Trials Market - Revenue and Forecast to 2028 - Country Analysis

10.1 Europe: Clinical Trials Market
- 10.1.1 Overview
- 10.1.2 Europe: Clinical Trials Market, by Country, 2022 & 2028 (%)
  - 10.1.2.1 Germany: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.1.1 Overview
    - 10.1.2.1.2 Germany: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.1.3 Germany: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
    - 10.1.2.1.4 Germany: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
    - 10.1.2.1.5 Germany: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)
  - 10.1.2.2 UK: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.2.1 Overview
    - 10.1.2.2.2 UK: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.2.3 UK: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
    - 10.1.2.2.4 UK: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
    - 10.1.2.2.5 UK: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)
  - 10.1.2.3 France: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.3.1 Overview
    - 10.1.2.3.2 France: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.3.3 France: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
    - 10.1.2.3.4 France: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
    - 10.1.2.3.5 France: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)
  - 10.1.2.4 Italy: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.4.1 Overview
    - 10.1.2.4.2 Italy: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.4.3 Italy: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
    - 10.1.2.4.4 Italy: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
    - 10.1.2.4.5 Italy: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)
  - 10.1.2.5 Spain: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.5.1 Overview
    - 10.1.2.5.2 Spain: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.5.3 Spain: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
    - 10.1.2.5.4 Spain: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
    - 10.1.2.5.5 Spain: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)
  - 10.1.2.6 Rest of Europe: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.6.1 Overview
    - 10.1.2.6.2 Rest of Europe: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.6.3 Rest of Europe: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
    - 10.1.2.6.4 Rest of Europe: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
    - 10.1.2.6.5 Rest of Europe: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
- 11.3.1 Overview
11.4 Inorganic Developments
- 11.4.1 Overview

12. Company Profiles

12.1 IQVIA Holdings Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Parexel International Corp
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 IXICO Plc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Charles River Laboratories International Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 ICON Plc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 WuXi AppTec Co Ltd
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 SGS SA
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Syneos Health Inc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Thermo Fisher Scientific Inc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Laboratory Corp of America Holdings
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. Germany: Clinical Trials Market, by Phase - Revenue and Forecast to 2028 (US$ Million)
Table 2. Germany: Clinical Trials Market, by Study Design - Revenue and Forecast to 2028 (US$ Million)
Table 3. Germany: Clinical Trials Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 4. UK Clinical Trials Market, by Phase - Revenue and Forecast to 2028 (US$ Million)
Table 5. UK Clinical Trials Market, by Study Design - Revenue and Forecast to 2028 (US$ Million)
Table 6. UK Clinical Trials Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 7. France: Clinical Trials Market, by Phase - Revenue and Forecast to 2028 (US$ Million)
Table 8. France: Clinical Trials Market, by Study Design - Revenue and Forecast to 2028 (US$ Million)
Table 9. France: Clinical Trials Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 10. Italy: Clinical Trials Market, by Phase - Revenue and Forecast to 2028 (US$ Million)
Table 11. Italy: Clinical Trials Market, by Study Design - Revenue and Forecast to 2028 (US$ Million)
Table 12. Italy: Clinical Trials Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 13. Spain: Clinical Trials Market, by Phase - Revenue and Forecast to 2028 (US$ Million)
Table 14. Spain: Clinical Trials Market, by Study Design - Revenue and Forecast to 2028 (US$ Million)
Table 15. Spain: Clinical Trials Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 16. Rest of Europe: Clinical Trials Market, by Phase - Revenue and Forecast to 2028 (US$ Million)
Table 17. Rest of Europe: Clinical Trials Market, by Study Design - Revenue and Forecast to 2028 (US$ Million)
Table 18. Rest of Europe: Clinical Trials Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 19. Organic Developments Done by Companies
Table 20. Inorganic Developments Done by Companies
Table 21. Glossary of Terms

List Of Figures

Figure 1. Europe Clinical Trials Market Segmentation
Figure 2. Europe Clinical Trials Market, By Region
Figure 3. Europe Clinical Trials Market Overview
Figure 4. Phase III Segment Held Largest Share of Phase Segment in Europe Clinical Trials Market
Figure 5. The UK is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Europe: PEST Analysis
Figure 7. Europe Experts Opinion
Figure 8. Impact Analysis
Figure 9. Europe Clinical Trials Market- Revenue Forecast and Analysis - 2020- 2028
Figure 10. Europe Clinical Trials Market Revenue Share, by Study Design (2022 and 2028)
Figure 11. Interventional: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. Observational: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Expanded Access: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. Europe Clinical Trials Market, by Phase 2022 and 2028 (%)
Figure 15. Phase III: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 16. Phase II: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 17. Phase IV: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. Phase I: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. Europe Clinical Trials Market Revenue Share, by Indication (2022 and 2028)
Figure 20. Autoimmune/Inflammation: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Pain Management: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. Oncology: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. CNS Condition: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 24. Diabetes: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Obesity: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. Cardiovascular: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. Other: Europe Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. Europe: Clinical Trials Market, by Key Country - Revenue (2022) (US$ Million)
Figure 29. Europe: Clinical Trials Market, by Country, 2022 & 2028 (%)
Figure 30. Germany: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 31. UK: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 32. France: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 33. Italy: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 34. Spain: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 35. Rest of Europe: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 36. Growth Strategies Done by the Companies in the Market, (%)